Home / Rosuvastatin and Ezetimibe / Czechia
CZ ATC C10BA06 · updated 2 Nov 2026
Rosuvastatin and Ezetimibe shortage in Czechia
Is there a Rosuvastatin and Ezetimibe shortage in Czechia?
Yes. As of 2 Nov 2026, 1 Rosuvastatin and Ezetimibe product is reported short in Czechia, the first since 12 Jun 2026. The company estimate for the return is 30 Nov 2026. Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Austria, Belgium. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | DELIPID PLUS 10MG/10MG 10MG/10MG CPS DUR 30 | Egis Pharmaceuticals PLC, Budapešť | 12 Jun 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.